Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05230212 · ClinicalTrials.gov registry record · NA
Pecan Consumption and Cognitive Function
A NA study, sponsored by University of Georgia.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05230212 is a NA study that has completed, run by University of Georgia. The registered enrollment target is 31 participants.
The verdict
NCT05230212, a NA study, has completed, sponsored by University of Georgia.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
Human cognitive function is affected by age-related changes, with some areas beginning to decline in mid-adulthood and worsening with age. However, there is evidence that dietary interventions or the incorporation of certain healthy foods or nutrients, into the diet can have protective effects against cognitive decline. These foods include nutrients such as polyunsaturated fats, vitamins E and C, and polyphenols. Pecans are a rich source of polyunsaturated fatty acids, antioxidants (including polyphenols), and vitamin E. Pecans contain more total phenols than any other tree nut suggesting that they may be an ideal bioactive food to enhance cognitive performance; however, the relationship between pecan consumption and cognitive functioning has never been assessed. The overall goal behind this research is to determine the relationship between antioxidant-rich pecans and cognitive functioning in a postprandial state.
Interventions
- OTHER Pecan Breakfast Shake
- OTHER Cream Breakfast Shake
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2023-02-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05230212
The ClinicalTrials.gov registry entry for NCT05230212 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Georgia, which has 59 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pecan Breakfast Shake is the first listed.
NCT05230212 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05230212 about?
NCT05230212 is a clinical study titled "Pecan Consumption and Cognitive Function". Human cognitive function is affected by age-related changes, with some areas beginning to decline in mid-adulthood and worsening with age. However, there is evidence that dietary interventions or the incorporation of certain healthy foods or nutrients, into the diet can have protective effects again...
What is the current status of trial NCT05230212?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2021-02-01. Estimated completion is 2023-02-25.
What interventions are being tested in trial NCT05230212?
The interventions under investigation include: Pecan Breakfast Shake (OTHER), Cream Breakfast Shake (OTHER).
Who is sponsoring clinical trial NCT05230212?
This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.